Fingerprint
Dive into the research topics of 'Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically